PDI - Resultado de Búsqueda

Jana Stojanova

Profesor Auxiliar

Universidad de Valparaíso

Viña del Mar, Chile

Post-transplant lymphoproliferative disease; immunosuppressants; transplantation; pharmacogenetics; pharmacokinetics; epidemiology; design and execution of clinical research

PhD Biology-Health, Pharmacology, UNIVERSIDAD DE LIMOGES. Francia, 2013
Pharmacy, UNIVERSITY OF SYDNEY. Australia, 2006
Quimico Farmaceutico, UNIVERSIDAD DE CHILE. Chile, 2018

Clinical Coordinator Full Time

UNIVERSIDAD DE VALPARAISO

Chile

2015 - 2019
Editorial Coordinator Part Time

UNIVERSIDAD DE CHILE

Chile

2013 - 2015
Research Assistant Part Time

UNIVERSIDAD DE CHILE

Chile

2014 - 2015
Profesor Auxiliar Part Time

UNIVERSIDAD DE VALPARAISO

Medicine

Chile

2020 - A la fecha

Clinical Pharmacist Full Time

The Canberra Hospital

Australia

2006 - 2009
Doctoral Contract Full Time

Université de Limoges

Francia

2009 - 2013
Learning and Support Officer (Group Staff) Part Time

Cochrane

Reino Unido

2020 - A la fecha

Apoyo en diseño metodologico y ejecución para validación clínica de varios proyectos de innovación, apoyados por Corfo, Fondef, MINEDUC


General concepts in biostatistics and clinical epidemiology: Experimental studies with randomized clinical trial design. ESTRADA, S.; Arancibia, M.; Stojanova, J Article MEDWAVE (2020)
How to design a study to evaluate therapeutic drug monitoring in infectious diseases? Märtson AG; Sturkenboom MG; Stojanova, J; et al. Article CLINICAL MICROBIOLOGY AND INFECTION (2020)
Main concepts on bioequivalence and biosimilarity in the Chilean legislation, and current controversies on drug interchangeability. Stojanova, J; Lutz, M; Lazcano, G; et al. Article MEDWAVE (2020)
Psychotropic drug concentrations and clinical outcomes in children and adolescents Kloosterboer, Sanne M.; Vierhout, Denise; Stojanova, Jana; et al. Article EXPERT OPINION ON DRUG SAFETY (2020)
Default Mode Network, Meditation, and Age-Associated Brain Changes: What Can We Learn from the Impact of Mental Training on Well-Being as a Psychotherapeutic Approach? Ramirez-Barrantes, Ricardo; Arancibia, Marcelo; Stojanova, Jana; Aspe-Sanchez, Mauricio; Cordova,Claudio; Henriquez-Ch, Rodrigo A. Article ISI SCOPUS NEURAL PLASTICITY (2019)
General concepts in biostatistics and clinical epidemiology: observational studies with case-control design. Martínez D; Papuzinski C.; Stojanova, J; et al. Article MEDWAVE (2019)
General concepts in biostatistics and clinical epidemiology: Observational studies with cross-sectional and ecological designs. Cataldo, R.; Arancibia, M.; Stojanova, J Article MEDWAVE (2019)
Placental structure in gestational diabetes mellitus Carrasco-Wong, I; Moller, A; Stojanova, J Article BIOCHIMICA ET BIOPHYSICA ACTA (2019)
Using systematic reviews in the scientific substantiation of health properties of foods and food constituents. Lutz, M; Arancibia, M.; Stojanova, J Article MEDWAVE (2019)
Corneal endothelial cell loss associated to phacoemulsification and ophthalmologist experience: prospective analysis of individual secondary data Chamorro, Fernando; Briones, Cristobal; Loezar, Cristobal; Leon, Alex; Arancibia, Marcelo; Stojanova, Jana; Madrid, Eva Article WOS-ESCI SCOPUS MEDWAVE (2018)
Therapeutic drug monitoring: More than avoiding toxicity Stojanova, J; Luque S. Article SCOPUS Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill (2017)
A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation Pouché L.; Koitka M.; Stojanova, J; Woillard J.-B.; Monchaud C.; Villeneuve C.; Essig M.; Abraham J.; Le Meur Y.; Rerolle J.-P.; Kamar N.; Rostaing L.; Merville P.; Gandia P.; Bouchet S.; Petersen B.-S.; Marquet, P; Picard N. Article ISI SCOPUS Pharmacogenomics (2016)
Genetic polymorphisms in the immune response: A focus on kidney transplantation Stojanova, J; Pouché L.; Picard N. Article ISI SCOPUS CLINICAL BIOCHEMISTRY (2016)
Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections Lamoureux, F; Duflot, T; Woillard, JB; Metsu, D; Pereira, T.; Compagnon, P; Morisse-Pradier, H; El Kholy, M; Thiberville, L; Stojanova, J; Thuillez, C Article ISI SCOPUS INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses Varela, N; Quinones, LA; Stojanova, J; Garay, J; Caceres D.; Cespedes, S; Sasso, J.; Miranda, C. Article ISI SCOPUS Pharmacological Research (2015)
Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants Stojanova, Jana; Caillard, Sophie; Rousseau, Annick; Marquet, Pierre Article ISI PHARMACOLOGICAL RESEARCH (2011)
The FcγRIIIA‐158 VV genotype increased the risk of post‐transplant lymphoproliferative disorder in T‐cell depleted kidney transplant recipients. Gatault P; Lajoie L; Stojanova, J; et al. Article TRANSPLANT INTERNATIONAL


Erratum: Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses (Pharmacological Research (2015) 101 (124-129) DOI: 10.1016/j.phrs.2015.07.020) Varela, N; Quiñones L.A.; Stojanova, J; Garay, J; Caceres D.; Cespedes, S; Sasso, J.; Miranda, C. Errata ISI SCOPUS (2016)


New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs Pouché L.; Stojanova, J; Marquet, P; Picard N. Review ISI SCOPUS PHARMACOGENOMICS (2016)
Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy? Roco, A; Cayun J; Contreras S.; Stojanova, J; Quinones, L Review ISI SCOPUS Frontiers in Genetics (2014)